ACCREDITATION INFORMATION
TOPIC
IF I TOLD YOU ONCE, I TOLD YOU A THOUSAND TIMES: RECURRING ISSUES THAT GET YOU SUED
TOPIC
NON-OPIOID PAIN MANAGEMENT
Speaker: ALAN LEMBITZ, MD
Speaker: JONATHAN CLAPP, MD
Location: IN-PERSON AT THE HILTON FORT COLLINS
Location: IN-PERSON AT THE CUSOM-FSB
Date And Time: SATURDAY, APRIL 23, 9:30-10:30 A.M.
Date and time: SATURDAY, APRIL 23, 12:30-1:30 P.M.
A review of areas where COPIC most frequently
• Identify specific sub-types of pain to guide treatment.
sees medical liability cases as well as a summary
• Describe non-opioid evidence-based treatments for pain.
of ways to reduce your risk exposure and improve patient safety in these areas.
• Recognize the importance of addressing psychiatric and psychologic comorbities in pain treatment.
• Identify areas that are higher risk for patient safety and how to reduce this risk. • Recognize when you are in a situation that warrants heightened vigilance. • Explain how you can improve patient safety This presentation is valid for 1 COPIC point. ACCME ACCREDITATION STATEMENT The Colorado Medical Society is accredited by the Accreditation Council for Continuing Medical Education
ACCME ACCREDITATION STATEMENT The Colorado Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AMA CREDIT DESIGNATION STATEMENT The Colorado Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
to provide continuing medical education for physicians. AMA CREDIT DESIGNATION STATEMENT The Colorado Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 14
Disclosure of relevant financial relationships: The faculty, planners, and all others in control of content have no relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
A P R IL R E G IO NA L SU M M IT A ND BOA R D O F D I R EC TO R S M EET I N G
